What is the current valuation of the Blood Plasma Derivatives Market as of 2024?

The Blood Plasma Derivatives Market was valued at 43.3 USD Billion in 2024. Read More

What is the projected market size for the Blood Plasma Derivatives Market by 2035?

The market is projected to reach 86.67 USD Billion by 2035. Read More

What is the expected CAGR for the Blood Plasma Derivatives Market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 6.47%. Read More

Which application segments are driving growth in the Blood Plasma Derivatives Market?

The application segments include Immunology, Hematology, Neurology, Oncology, and Infectious Diseases, with valuations ranging from 6.5 to 22.35 USD Billion. Read More

What are the key product types in the Blood Plasma Derivatives Market?

Key product types include Albumin, Immunoglobulin, Coagulation Factors, Clotting Factor Concentrates, and Fibrinogen, with valuations from 5.0 to 30.0 USD Billion. Read More

Who are the leading companies in the Blood Plasma Derivatives Market?

Key players in the market include Grifols, CSL Behring, Takeda Pharmaceutical Company Limited, Octapharma, and Kedrion S.p.A. Read More

What end-use segments are contributing to the Blood Plasma Derivatives Market?

End-use segments include Hospitals, Clinics, Research Laboratories, Blood Banks, and Pharmaceutical Companies, with valuations from 6.0 to 24.67 USD Billion. Read More

How does the market for Immunoglobulin compare to other product types?

Immunoglobulin is projected to have a valuation of 15.0 to 30.0 USD Billion, making it one of the leading product types. Read More

What is the significance of the Oncology segment in the Blood Plasma Derivatives Market?

The Oncology segment is projected to grow from 9.0 to 18.0 USD Billion, indicating its critical role in market expansion. Read More

How are research laboratories positioned in the Blood Plasma Derivatives Market?

Research Laboratories are expected to contribute between 7.0 and 14.0 USD Billion, highlighting their importance in the market. Read More

Blood Plasma Derivatives Market

ID: MRFR/Pharma/0817-HCR

80 Pages

Nidhi Mandole

Last Updated: May 11, 2026

血浆衍生物市场研究报告信息按类型[因子VIII浓缩物、因子IX浓缩物、白蛋白、免疫球蛋白、抗凝血酶III浓缩物和新鲜冷冻血浆（FFP）]、应用（HIV、甲型血友病、乙型血友病、乙型肝炎、丙型肝炎、出血性疾病、低丙种球蛋白血症、免疫缺陷疾病和其他）、最终用户（医院和诊所、输血中心、诊断中心等）和地区（美洲、欧洲、亚太地区、中东和非洲）—到 2032 年的预测

Blood Plasma Derivatives Market Infographic

摘要目录分割方法论下载PDF

2.1 定义
1. 2.2 研究范围
  1. 2.2.1 研究目标
  2. 2.2.2 假设
  3. 2.2.3 局限性
2. 3.1 概述
3. 3.2 初步研究
4. 3.3 二次研究
5. 3.4 市场规模估算
6. 4.1 驱动因素
7. 4.2 限制因素
8. 4.3 机遇
9. 4.4 挑战
10. 5.1 波特五力分析
  1. 5.1.1 供应商的议价能力
  2. 5.1.2 买方的议价能力
  3. 5.1.3 新进入者的威胁
  4. 5.1.4 替代品的威胁
  5. 5.1.5 竞争强度
11. 5.2 价值链分析
12. 6.1 概述
13. 6.2 因子 VIII 浓缩物
14. 6.3 因子 IX 浓缩物
15. 6.4 白蛋白
16. 6.5 免疫球蛋白
17. 6.6 抗凝血酶III浓缩物
18. 6.7 新鲜冷冻血浆 (FFP)
19. 7.1 概述
20. 7.2 艾滋病毒
21. 7.3 甲型血友病
22. 7.4 乙型血友病
23. 7.5 乙型肝炎
24. 7.6 丙型肝炎
25. 7.7 出血性疾病
26. 7.8 低丙种球蛋白血症
27. 7.9 免疫缺陷疾病
28. 7.10 其他
29. 8.1 概述
30. 8.2 医院和诊所
31. 8.3 输血中心
32. 8.4 诊断中心
33. 8.5 其他
34. 10.1 概述
35. 10.2 美洲
  1. 10.2.1 北美
    1. 10.2.1.1 美国
    2. 10.2.1.2 加拿大
  2. 10.2.2 拉丁美洲
36. 10.3 欧洲
  1. 10.3.1 西欧
    1. 10.3.1.1 德国
    2. 10.3.1.2 法国
    3. 10.3.1.3 意大利
    4. 10.3.1.4 西班牙
    5. 10.3.1.5 英国
    6. 10.3.1.6 西欧其他地区
  2. 10.3.2 东欧
37. 10.4 亚太地区
  1. 10.4.2 中国
  2. 10.4.3 印度
  3. 10.4.4 澳大利亚
  4. 10.4.5 韩国
  5. 10.4.6 亚太其他地区
38. 10.5 中东及非洲
  1. 10.5.1 中东
  2. 10.5.2 非洲
39. 11.1 概述
40. 11.2 竞争分析
41. 12.1 百特生物科学
  1. 12.1.1 公司概况
  2. 12.1.2 产品类型概述
  3. 12.1.3 财务概况
  4. 12.1.4 关键发展
  5. 12.1.5 SWOT分析
42. 12.2 Grifols S.A.
  1. 12.2.1 公司概况
  2. 12.2.2 产品类型概述
  3. 12.2.3 财务概况
  4. 12.2.4 关键发展
  5. 12.2.5 SWOT 分析
43. 12.3 CSL Behring
  1. 12.3.1 公司概况
  2. 12.3.2 产品类型概况
  3. 12.3.3 财务概况
  4. 12.3.4 关键发展
  5. 12.3.5 SWOT 分析
44. 12.4 ViroPharma, Inc.
  1. 12.4.1 公司概况
  2. 12.4.2 产品类型概况
  3. 12.4.3 财务概况
  4. 12.4.4 关键发展
  5. 12.4.5 SWOT 分析
45. 12.5 Talecris Biotherapeutics,公司
  1. 12.5.1 公司概况
  2. 12.5.2 产品类型概况
  3. 12.5.3 财务概况
  4. 12.5.4 关键发展
  5. 12.5.5 SWOT 分析
46. 12.6 Octapharma
  1. 12.6.1 公司概况
  2. 12.6.2 产品类型概况
  3. 12.6.3 财务概况
  4. 12.6.4 关键发展
  5. 12.6.5 SWOT 分析
47. 12.7 Fusion Healthcare
  1. 12.7.1 概况
  2. 12.7.2 产品类型概况
  3. 12.7.3 财务概况
  4. 12.7.4 关键发展
  5. 12.7.5 SWOT 分析
48. 12.8 SK Plasma 有限公司
  1. 12.8.1 概述
  2. 12.8.2 产品类型概述
  3. 12.8.3 财务概览
  4. 12.8.4 关键发展
  5. 12.8.5 SWOT 分析
49. 12.9 Biotest AG
  1. 12.9.1 概述
  2. 12.9.2 产品类型概述
  3. 12.9.3 财务概览
  4. 12.9.4 关键发展
  5. 12.9.5 SWOT 分析
50. 12.10 绿十字公司
  1. 12.10.1 概述
  2. 12.10.2 产品类型概述
  3. 12.10.3 财务概览
  4. 12.10.4 关键发展
  5. 12.10.5 SWOT 分析
51. 12.11 Shire Plc
  1. 12.11.1 概述
  2. 12.11.2 产品类型概述
  3. 12.11.3 财务概览
  4. 12.11.4 关键发展
  5. 12.11.5 SWOT 分析
52. 12.13 其他
53. 13.1 参考文献
54. 13.2 相关报告

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

案例研究

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓

Blood Plasma Derivatives Market

相关报告

Customer Stories

Aerospace & Defense

Compare Licence